In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer
Cancer Biomarkers · 2026-06 · 43
DOI: 10.1177/18758592261463305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 23.06.2026. Verfasst von Kiarash Zare und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Stomach Neoplasms, Biomarkers, Tumor, Transcriptional Elongation Factors. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The main aim of this study is to identify prognostic biomarkers through integrating bioinformatics analysis in gastric cancer, which is a significant global health challenge.
Methods
Gene expression datasets related to blood, tissue, and saliva in gastric cancer were downloaded from the Gene Expression Omnibus (GEO) database and analyzed. The bioinformatics approaches included the identification of differentially expressed genes (DEGs) and enrichment analysis, as well as Kaplan-Meier Plotter survival analysis. The DEGs were also validated through The Cancer Genome Atlas (TCGA) database. Additionally, DEGs-associated lncRNAs and microRNAs were identified. Subsequently, Tumor and Immune System Interaction Database (TISIDB) was utilized to examine the correlation of the genes of interest with immune and molecular subtypes.
Results
Twenty-six common DEGs were identified across blood, tissue, and saliva samples. Among them, 17 genes showed significant expression based on TCGA data. RAB23, LOX, ELL2, ELK3, CENPF, CD44, ANP32E, AKR1C2, and SMAD5 displayed significant association with patient survival. Particularly, ELL2 exhibit decreased expression in all specimens. The results indicated that ELL2 has a significant correlation with the immune system. The ELL2 gene regulates immune cell functions in gastric cancer, potentially influencing cancer immune responses, and tumor progression.
Conclusion
ELL2 downregulated expression and its correlation with survival across blood, tissue, and saliva samples using bioinformatics analysis underscores the necessity of more investigation to fully comprehend its function in cancer immunology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
- Hematology, Oncology and Stem Cell Transplantation Research Center, Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran.
- Systems Biology Research Group, Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
- School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Centre, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mohammad Mehdi Naghizadeh
Zitieren
APA
Zare, K., Salehi, Z., Morovat, A. R., Aghajani, A., Mohammadi Pour, P., Ghanbariasad, A., & Naghizadeh, M. M. (2026). In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261463305
Vancouver
Zare K, Salehi Z, Morovat AR, Aghajani A, Mohammadi Pour P, Ghanbariasad A, et al. In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261463305
BibTeX
@article{Zare2026,
author = {Zare, Kiarash and Salehi, Zahra and Morovat, Ali Reza and Aghajani, Ali and Mohammadi Pour, Pardis and Ghanbariasad, Ali and Naghizadeh, Mohammad Mehdi},
title = {In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer},
journal = {Cancer Biomarkers},
year = {2026},
volume = {43},
doi = {10.1177/18758592261463305}
}
EUVIMED